Amineptin is a western medicine, the main ingredient is Amineptin, which belongs to the national non-medical insurance medicine, mainly used for the treatment of primary thrombocytopenic purpura, allergic purpura, leukopenia and aplastic anemia. Amineptin is a tablet, 0.2g per tablet, which is used mainly by oral administration, 1g per time for adults, that is, 5 tablets per time, and the dosage should be reduced for children as appropriate. It is used for at least 4 weeks and can be taken continuously if it is effective. Adverse reactions to the use of Amineptine are not known at present, and it is prohibited for those who are allergic to this product. When the drug properties change, stop using it to avoid adverse reactions.